Pediatr. praxi. 2020;21(5):369-373 | DOI: 10.36290/ped.2020.076

Acute disseminated encephalomyelitis

MUDr. Martin Chvojka1, MUDr. Josef Gut1, MUDr. Miroslav Jiránek2
1 Dětské oddělení Nemocnice s Poliklinikou Česká Lípa
2 Dětská klinika Masarykova nemocnice v Ústí nad Labem

Acute disseminated encephalomyelitis (ADEM) is an autoimmune demyelinating disease of the central nervous system that occurs most often after an infection, typically in children and adolescents. The clinical picture is dominated by encephalopathy and various neurological deficits. Since ADEM bears resemblance to other demyelinating syndromes of childhood, the diagnosis has to be made by excluding other ethiologies, such as multiple sclerosis, although the patient history, clinical findings and imaging methods makes it readily distinguishable. Treatment of choice for ADEM is high-dose cocorticosteroids, altough intravenous immunoglobulins or plasmapheresis may be used as well. In our case report, we present eight-year-old girl with ADEM. This girl had typical findings for the disease and was a good responder to high-dose corticosteroid therapy. She made total recovery without any comlications or sequelae.

Keywords: acute disseminated encephalomyelitis, ADEM, myelin oligodendrocyte glycoprotein, corticotherapy, IVIG, plasmapheresis.

Published: October 16, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Chvojka M, Gut J, Jiránek M. Acute disseminated encephalomyelitis. Pediatr. praxi. 2020;21(5):369-373. doi: 10.36290/ped.2020.076.
Download citation

References

  1. Kliegman MR, Stanton FB, St Geme JW, Schor NF, Nelson Texbook of pediatrics, Twentieth edition, Elsevier 2016, Chapter 600: Demyelinating Disorders of the Central Nervous System (Jayne M. Ness); 2919-2925.
  2. Cole J, Evans E, Mwangi M, Mar S. Acute Disseminated Encephalomyelitis in Children: An Updated Review Based on Current Diagnostic Criteria. Pediatr Neurol 2019; 100: 26. Go to original source... Go to PubMed...
  3. Dulac O, Lassonde M, Sarnat HB, Editors, Handbook of Clinical Neurology, Vol. 112 (3rd series), Pediatric Neurology Part II, Elsevier 2013, Chapter 113: Acute disseminated encephalomyelitis, Tenembaum S.
  4. Alper G. Acute disseminated encephalomyelitis. J Child Neurol. 2012 Nov. 27(11): 1408-1425. Go to original source... Go to PubMed...
  5. Bray PF, Luka J, Bray PF, et al. Antibodies against Epstein‑Barr nuclear antigen (EBNA) in multiple sclerosis CSF, and two pentapeptide sequence identities between EBNA and myelin basic protein. Neurology 1992; 42: 1798. Go to original source... Go to PubMed...
  6. Tenembaum S, Chamoles N, Fejerman N. Acute disseminated encephalomyelitis: a long‑term follow‑up study of 84 pediatric patients. Neurology 2002; 59: 1224. Go to original source... Go to PubMed...
  7. Pohl D, Alper G, Van Haren K, Kornberg AJ, Lucchinetti CF, Tenembaum S, Belman AL. Acute disseminated encephalo- myelitis: Updates on an inflammatory CNS syndrome. Neurology 2016; 87(9 Suppl. 2): S38-S45. Go to original source... Go to PubMed...
  8. Beneš J. Infekční lékařství, Galén 2009, Infekce nervového systému; 509-534.
  9. Libá Z. Autoimunitní onemocnění centrálního nervového systému u dětí: současný pohled a terminologie. Neurologie pro praxi 2018; 19(2) 96-99. Go to original source...
  10. Krupp LB, Tardieu M, Amato MP, et al. International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune- mediated central nervous system demyelinating disorders: revisions to the 2007 definitions. Mult Scler 2013; 19: 1261. Go to original source... Go to PubMed...
  11. Tenembaum S, Chitnis T, Ness J, et al. Acute disseminated encephalomyelitis. Neurology 2007; 68: S23. Go to original source... Go to PubMed...




Pediatrics for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.